WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION Trademark

Trademark Overview

On Tuesday, October 27, 2009, a trademark application was filed for WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION with the United States Patent and Trademark Office. The USPTO has given the WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION trademark a serial number of 77857972. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 25, 2022. This trademark is owned by Daiichi Sankyo, Inc.. The WELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the reduction of elevated cholesterol in patients having primary hypercholesterolemia; pharmaceutical preparations for the treatment of diabetes

General Information

Serial Number77857972
Word MarkWELCHOL (COLESEVELAM HCI) FOR ORAL SUSPENSION
Filing DateTuesday, October 27, 2009
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 25, 2022
Registration Number4020034
Registration DateTuesday, August 30, 2011
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 4, 2010

Trademark Statements

Description of MarkThe mark consists of two arrows which appear to left of the word "WELCHOL". The larger, outer arrow appears in the colors blue and green and the arrow connects to the right-hand portion of the letter "W" in the word "WELCHOL", which is in the color green. The smaller, inner arrow appears in the colors yellow and green and connects to the left-hand portion of the letter "W" in "WELCHOL". Both arrows converge to the left of the word "WELCHOL", sharing the same green arrowhead. The letter "W" in "WELCHOL" is capitalized. The words "COLESEVELAM HCI", enclosed in parentheses, appear in small, black letters, immediately beneath the "LCHOL" portion of the word "WELCHOL". The parenthesis are also black. The words "FOR ORAL SUSPENSION" appear immediately beneath "(COLESEVELAM HCI)" in the color green.
Goods and ServicesPharmaceutical preparations for the reduction of elevated cholesterol in patients having primary hypercholesterolemia; pharmaceutical preparations for the treatment of diabetes
Indication of Colors claimedThe color(s) blue, green, yellow and black is/are claimed as a feature of the mark.
NOT AVAILABLE"COLESEVELAM HCI" AND "FOR ORAL SUSPENSION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 30, 2009
Primary Code005
First Use Anywhere DateTuesday, January 5, 2010
First Use In Commerce DateTuesday, January 5, 2010

Trademark Owner History

Party NameCOSETTE PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBRIDGEWATER, NJ 08807
Party NameDaiichi Sankyo, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasking Ridge, NJ 07920
Party NameDaiichi Sankyo, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameDaiichi Sankyo, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Tuesday, March 9, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 9, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 30, 2009NEW APPLICATION ENTERED
Friday, October 30, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 31, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, February 1, 2010ASSIGNED TO EXAMINER
Wednesday, February 3, 2010NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2010NON-FINAL ACTION E-MAILED
Wednesday, February 3, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 10, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 21, 2010SOU EXTENSION 1 FILED
Monday, March 15, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2010ASSIGNED TO LIE
Tuesday, March 30, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 4, 2010PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2010SOU TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010SOU EXTENSION 1 GRANTED
Tuesday, August 30, 2011REGISTERED-PRINCIPAL REGISTER
Thursday, December 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 17, 2011TEAS STATEMENT OF USE RECEIVED
Friday, June 17, 2011USE AMENDMENT FILED
Monday, June 27, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 22, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 28, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 28, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, July 29, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 11, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 30, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 21, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, August 28, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 28, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 28, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, August 30, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 16, 2021TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 25, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 25, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 25, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, February 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

suspension oral colesevelam welchol pharmaceutical preparations hypercholesterolemia diabetes primary treatment patients reduction elevated cholesterol